Skip to main content

Research Repository

Advanced Search

All Outputs (4)

High-intensity interval training in patients with intermittent claudication (2023)
Presentation / Conference Contribution
Pymer, S., Harwood, A. E., Prosser, J., Waddell, A., Rhavindhran, B., McGregor, G., Ibeggazene, S., Huang, C., Twiddy, M., Nicholls, A. R., Ingle, L., Carroll, S., He, H., Long, J., Rooms, M., & Chetter, I. C. High-intensity interval training in patients with intermittent claudication. Presented at 2022 Vascular Society of Great Britain and Ireland Annual Scientific Meeting, Brighton, UK

Objective: Provision, uptake, adherence, and completion rates for supervised exercise programs (SEP) for intermittent claudication (IC) are low. A shorter, more time-efficient, 6-week, high-intensity interval training (HIIT) program may be an effecti... Read More about High-intensity interval training in patients with intermittent claudication.

Effectiveness of a six-week high-intensity interval training programme on cardiometabolic markers in sedentary males (2014)
Presentation / Conference Contribution
Gleadall-Siddall, D., Burke, R., Gritt, J., O'Carroll, G., Bray, J., Ingle, L., & Garrett, A. (2014). Effectiveness of a six-week high-intensity interval training programme on cardiometabolic markers in sedentary males. . https://doi.org/10.1080/02640414.2014.968390

High-intensity interval training (HIT) has been proposed as an effective, time efficient strategy to elicit similar cardiometabolic health benefits as traditional moderate-intensity endurance training. This is an important consideration as "lack of t... Read More about Effectiveness of a six-week high-intensity interval training programme on cardiometabolic markers in sedentary males.

Clinical trials update from the European Society of Cardiology Heart Failure meeting and the American College of Cardiology: Darbepoetin alfa study, ECHOS, and ASCOT-BPLA (2005)
Presentation / Conference Contribution
Cleland, J. G., Coletta, A. P., Clark, A. L., Velavan, P., & Ingle, L. (2005). Clinical trials update from the European Society of Cardiology Heart Failure meeting and the American College of Cardiology: Darbepoetin alfa study, ECHOS, and ASCOT-BPLA. European journal of heart failure, 7(5), 937-939. https://doi.org/10.1016/j.ejheart.2005.07.001

This article provides information and a commentary on landmark trials presented at the European Society of Cardiology Heart Failure meeting held in June 2005, relevant to the pathophysiology, prevention and treatment of heart failure. All reports sho... Read More about Clinical trials update from the European Society of Cardiology Heart Failure meeting and the American College of Cardiology: Darbepoetin alfa study, ECHOS, and ASCOT-BPLA.